Remedium unveils Rights Issue post Rs. 182.7 crore UK deal to drive global expansion
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Increases speed to market for drug developers working on nucleic acid therapeutics
Acquisition expands high-value medical platform
Exploring new opportunities within the fast-growing market of microfluidics
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
The inspection concluded with the issuance of Form 483 with four observations which are procedural in nature
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Subscribe To Our Newsletter & Stay Updated